New-onset diabetes after liver transplantation (NODAT) is increasingly recognized as a complication that affects the quality of life. In addition to well-known risk factors for diabetes in such patients, little is known regarding the genetic predisposition for this condition.
(2022). Recipient IL28B Variant as Predictor of New Onset Diabetes Mellitus in Liver Transplant Patients with Chronic Hepatitis C. Egyptian Society of Diabetes and Lipidology Journal, 2(2), -. doi: 10.21608/esdlj.2022.455804
MLA
. "Recipient IL28B Variant as Predictor of New Onset Diabetes Mellitus in Liver Transplant Patients with Chronic Hepatitis C", Egyptian Society of Diabetes and Lipidology Journal, 2, 2, 2022, -. doi: 10.21608/esdlj.2022.455804
HARVARD
(2022). 'Recipient IL28B Variant as Predictor of New Onset Diabetes Mellitus in Liver Transplant Patients with Chronic Hepatitis C', Egyptian Society of Diabetes and Lipidology Journal, 2(2), pp. -. doi: 10.21608/esdlj.2022.455804
VANCOUVER
Recipient IL28B Variant as Predictor of New Onset Diabetes Mellitus in Liver Transplant Patients with Chronic Hepatitis C. Egyptian Society of Diabetes and Lipidology Journal, 2022; 2(2): -. doi: 10.21608/esdlj.2022.455804
)
